Cardinal Health, Inc.
Cardinal Health, Inc. (CAH) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cah · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cardinal Health, Inc. (CAH) measures how much investors pay for each dollar of the company's trailing earnings. CAH's current PE ratio of 30.98x is calculated by dividing its stock price of $204.48 by its TTM earnings per share of $6.63. −7.0% discount vs 5Y avg 33.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 18 fiscal years · Front-end computedMinQ1 · 25%19.6x
MedianQ3 · 75%74.8x
Max
At 30.98x, CAH's current P/E is higher than in 83% of its annual fiscal year readings over the past 18 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Distribution · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cardinal Health, Inc.You CAH | $47.9B | 30.98x | -15.0% | $6.63 |
 Agilent Technologies, Inc. A | $37.5B | 31.79x | -12.8% | $4.60 |
 argenx SE ARGX | $54.6B | 39.90x | +9.5% | $21.08 |
 Becton, Dickinson and Company BDX | $54.3B | 25.13x | -31.0% | $5.85 |
 Bruker Corporation BRKR | $8.6B | N/A | — | -$0.06 |
 Cencora, Inc. COR | $53.3B | 38.98x | +6.9% | $8.02 |
 Edwards Lifesciences Corporation EW | $49.4B | 46.44x | +27.4% | $1.84 |
Industry Average 5 peers with valid PE | — | 36.45x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | 25.94x | $6.48 | -7.7% | |
2024-06-30 FY2024 | 28.11x | $3.48 | -62.4% | |
2023-06-30 FY2023 | 74.80x | $1.26 | — | |
2022-06-30 FY2022 | — | $-3.36 | — | |
2021-06-30 FY2021 | 27.28x | $2.09 | — | |
2020-06-30 FY2020 | — | $-12.60 | — | |
2019-06-30 FY2019 | 10.47x | $4.54 | -82.5% | |
2018-06-30 FY2018 | 59.70x | $0.82 | +211.3% | |
2017-06-30 FY2017 | 19.18x | $4.06 | +7.3% | |
2016-06-30 FY2016 | 17.88x | $4.36 | -21.8% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cardinal Health, Inc. (CAH) measures how much investors pay for each dollar of the company's trailing earnings. CAH's current PE ratio of 30.98x is calculated by dividing its stock price of $204.48 by its TTM earnings per share of $6.63.
Frequently asked questions
CAH pe ratio · 6 questionsCAH's current PE ratio is 30.98x as of 2026-06-08, based on a stock price of $204.48 and TTM EPS of $6.63. Data sourced from Financial Modeling Prep via CAH's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cardinal Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08